Total Payments
$10,612
2024 Payments
$454.17
Companies
40
Transactions
584
Medicare Patients
13,317
Medicare Billing
$649,712
Payment Breakdown by Category
Food & Beverage$10,593 (99.8%)
Education$19.02 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,593 | 580 | 99.8% |
| Education | $19.02 | 2 | 0.2% |
| Unspecified | $0 | 2 | 0.0% |
Payments by Type
General
$10,612
582 transactions
Ownership
$0
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $2,122 | 114 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,661 | 99 | $0 (2024) |
| Amgen Inc. | $1,583 | 55 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $825.77 | 56 | $0 (2024) |
| PFIZER INC. | $771.31 | 52 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $496.44 | 30 | $0 (2023) |
| Boston Scientific Corporation | $460.12 | 20 | $0 (2024) |
| Medtronic Vascular, Inc. | $453.50 | 35 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $264.39 | 21 | $0 (2024) |
| Novo Nordisk Inc | $258.99 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $454.17 | 24 | Novartis Pharmaceuticals Corporation ($53.18) |
| 2023 | $1,213 | 57 | Janssen Pharmaceuticals, Inc ($243.80) |
| 2022 | $1,920 | 110 | Janssen Pharmaceuticals, Inc ($519.69) |
| 2021 | $1,763 | 90 | Janssen Pharmaceuticals, Inc ($754.65) |
| 2020 | $990.38 | 49 | Amgen Inc. ($360.30) |
| 2019 | $1,995 | 110 | Novartis Pharmaceuticals Corporation ($359.98) |
| 2018 | $1,388 | 87 | Novartis Pharmaceuticals Corporation ($358.91) |
| 2017 | $888.62 | 57 | PFIZER INC. ($142.48) |
All Payment Transactions
584 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/04/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Cardiology | ||||||
| 11/27/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: DIABETES | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.45 | General |
| Category: Cardiovascular | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Obesity | ||||||
| 10/24/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Cardiology | ||||||
| 10/23/2024 | Vital Connect, Inc | VITALPATCH RTM (Device) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: CARDIOLOGY | ||||||
| 10/17/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Cardiology | ||||||
| 10/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: DIABETES | ||||||
| 10/02/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.99 | General |
| Category: Cardiovascular | ||||||
| 10/01/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Cardiology | ||||||
| 09/23/2024 | Vital Connect, Inc | VITALPATCH RTM (Device) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: CARDIOLOGY | ||||||
| 09/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Cardiology | ||||||
| 09/05/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/04/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.72 | General |
| Category: Cardiovascular | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/26/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $29.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/19/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/30/2024 | Siemens Medical Solutions USA, Inc. | Artis icono floor (Device) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: AT - Fixed interventional x-ray/angiography fluoroscopy | ||||||
| 09/07/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,297 | 3,533 | $340,917 | $100,256 |
| 2022 | 23 | 3,541 | 6,074 | $557,555 | $175,156 |
| 2021 | 25 | 3,544 | 6,506 | $589,286 | $188,613 |
| 2020 | 28 | 3,935 | 7,608 | $630,192 | $185,687 |
Total Patients
13,317
Total Services
23,721
Medicare Billing
$649,712
Procedure Codes
108
All Medicare Procedures & Services
108 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 269 | 321 | $69,015 | $24,188 | 35.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 237 | 244 | $35,380 | $11,777 | 33.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 210 | 215 | $42,785 | $10,614 | 24.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 85 | 85 | $54,348 | $9,436 | 17.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 635 | 1,046 | $20,920 | $6,468 | 30.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 59 | 61 | $16,592 | $5,668 | 34.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 61 | 92 | $13,340 | $5,633 | 42.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 95 | 95 | $19,000 | $4,995 | 26.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 39 | 51 | $10,710 | $4,254 | 39.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $8,450 | $2,752 | 32.6% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 41 | 337 | $8,088 | $2,269 | 28.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 15 | $4,350 | $1,669 | 38.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 13 | 15 | $4,350 | $1,545 | 35.5% |
| 85610 | Blood test, clotting time | Office | 2023 | 41 | 355 | $4,970 | $1,491 | 30.0% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 95 | 95 | $6,650 | $1,394 | 21.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 84 | 121 | $1,694 | $1,016 | 60.0% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 15 | 15 | $3,075 | $966.30 | 31.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 95 | 95 | $5,700 | $931.26 | 16.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 68 | 77 | $4,620 | $736.92 | 16.0% |
| Q9950 | Injection, sulfur hexafluoride lipid microspheres, per ml | Office | 2023 | 12 | 59 | $1,180 | $713.33 | 60.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 14 | 15 | $1,200 | $578.25 | 48.2% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 30 | 30 | $2,444 | $555.35 | 22.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 32 | 37 | $1,591 | $485.44 | 30.5% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 27 | 31 | $465.00 | $119.35 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 401 | 578 | $124,270 | $46,896 | 37.7% |
About Dr. Stephen Rohn, M.D
Dr. Stephen Rohn, M.D is a Cardiovascular Disease healthcare provider based in Dalton, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689604472.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Rohn, M.D has received a total of $10,612 in payments from pharmaceutical and medical device companies, with $454.17 received in 2024. These payments were reported across 584 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($10,593).
As a Medicare-enrolled provider, Rohn has provided services to 13,317 Medicare beneficiaries, totaling 23,721 services with total Medicare billing of $649,712. Data is available for 4 years (2020–2023), covering 108 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Dalton, GA
- Active Since 07/04/2006
- Last Updated 07/09/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1689604472
Products in Payments
- XARELTO (Drug) $2,122
- ENTRESTO (Drug) $1,489
- Repatha (Biological) $1,057
- ELIQUIS (Drug) $665.46
- Corlanor (Drug) $526.56
- LifeVest (Device) $496.44
- BRILINTA (Drug) $494.26
- Resolute (Device) $334.66
- FARXIGA (Drug) $296.11
- WATCHMAN (Device) $286.76
- CHANTIX (Drug) $263.89
- LEQVIO (Drug) $172.07
- Ozempic (Drug) $159.69
- WATCHMAN Access System (Device) $155.93
- PRADAXA (Drug) $139.00
- JARDIANCE (Drug) $108.67
- NEXLETOL (Drug) $103.77
- PRALUENT (Drug) $103.55
- MRI Ready Leads (Device) $93.52
- ZIO XT Patch (Device) $85.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Dalton
Vineet Dua, M.d, M.D
Cardiovascular Disease — Payments: $207,557
Cardiovascular Disease $207,557
Dr. Yeunjung Kim, M.d, M.D
Cardiovascular Disease — Payments: $94,902
Cardiovascular Disease $94,902
Tharmathai Ramanan, Md, MD
Cardiovascular Disease — Payments: $17,007
Cardiovascular Disease $17,007
Dr. Gary Olson, M.d, M.D
Cardiovascular Disease — Payments: $15,067
Cardiovascular Disease $15,067
Dr. Ezad Ahmad, M.d, M.D
Cardiovascular Disease — Payments: $11,864
Cardiovascular Disease $11,864
Ji Hyun Lee, M.d, M.D
Cardiovascular Disease — Payments: $7,288
Cardiovascular Disease $7,288